MDR in few words

MDR in few words

In this blog post, I will try to briefly talk about the implementation of the MDR (Medical Device Regulation), a legal text that has been publicly preoccupying the medical device community from its adoption in May 2017.

Since that date, I have been managing the MDlaw Platform, where one could find all the relevant documents and information on the new law with the aim to increase the understanding of the MDR and consequently, become better prepared for the new requirements.

For 2 years and a half, I have been closely following the European Commission’s publications (implementing acts, decisions, factsheets) and optimistic forecasts about its implementation; MedTech Europe’s position papers, often full of concerns expressed by their members; discussions among regulatory experts, with still many open questions, and manufacturers aiming to get ready for May 2020.

It is almost impossible to summarize how to implement the new Regulation – without writing dozens of pages. I will therefore only enlist the most essential actions to take -  before MDR becomes applicable (in 7 months!):

  •  Read and re-read the legal text or check one of the e-books;
  •  Review your Quality Management and Risk Management Systems in light of MDR Article 10 and ISO 13485:2016 (manufacturers of Class I devices are not exempted from this requirement!);
  •  Re-asses the portfolio of your devices in view of classification changes and availability of sufficient clinical evidence;
  •  Review your technical documentation for your devices to align them with Annex II and III of the MDR;
  •  Review your clinical evaluation report (CER) in light of MDR Article 61 and Annex XIV;
  •  Implement a UDI system and assign basic UDI-DI to your devices; by 26 May 2020;
  •  Check accreditation status of your Notified Body under the MDR;
  •  Ensure you have a professional Authorised Representative (if based out of EU);
  •  As soon as EUDAMED becomes public, register yourself and obtain a SRN!
  •  Plan the recruitment of a Person Responsible for Regulatory Compliance;
  •  Envisage changes to the labelling, IFUs, promotional materials of your devices;
  •  Comply with post-market surveillance requirements specified in MDR Articles 83-92;
  •  Contract liability insurance;

Ajda Mihelcic

MDlaw.eu Content Manager

DPM of Publications department at Obelis

September 13, 2019


Remain continuously updated with MDR related news, clarifications of the legal requirements and receive other useful documents, e.g. checklists, templates at MDlaw Platform. Subscribe below and become a member today!

Become MDlaw member